An interventional study of acetylsalicylic acid in Hemodialysis, sponsored by Shanghai Jiao Tong University School of Medicine. Completed. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2014-10-23.
Sponsored by Shanghai Jiao Tong University School of Medicine · Not applicable, Interventional, and Prevention
The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.
This study prospectively evaluate the impacts of low dose aspirin on survival and cardio-cerebral vascular events in a large cohort of Chinese patients undergoing chronic hemodialysis. Between January 2008, consecutive patients with hemodialysis with aspirin were enrolled.We examine the association of aspirin with all-cause mortality in patients matched by propensity scores using the Kaplan-Meier method and Cox models in "intention-to-treat" analyses.The secondary endpoint was rate of cardio-cerebral events.
Shanghai Jiao Tong University School of Medicine is the lead sponsor of 358 studies on the registry; 104 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients aged 18 to 85, undergoing chronic hemodialysis, who have none of the following exclusion criteria.
Exclusion Criteria:
History of gastric or duodenal ulcers Known allergy to aspirin or other NSAIDs
-
Aspirin 75-100mg,per day，oral
Drug: acetylsalicylic acid
No interventions
75-100mg,per day
Also known as: Aspirin
survival rate
Time frame: 5 years
cardio-cerebral event
Time frame: 5 years
No study locations are listed for this record.
This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Jiao Tong University School of Medicine